9 Taro having a cash warchest of >US$ 1.2bn will look for an acquisition of specialty pharmaassetsintheUS.However,itindicatestoremaindisciplinedindeployingcash. 9 Taro has filed 10 ANDA in FY16 and expects it to maintain this runrate of filing for...